What changed in this filing

/stocks — the workspaceLOADING

Item 1. Financial Statements

2024-05-08 compared with 2023-11-02 · 146 added, 473 removed, 272 unchanged (69% of the section changed)

3 unchanged sentences

(In thousands, except per share data)

Three Months Ended Nine Months Ended

September 30,

2023 September 30,

2022 September 30,

2023 September 30,

Three Months Ended

2024 March 31,

Service revenue $ 53,465 $ 52,954

4 unchanged sentences

Cost of subscriber equipment sales 2,158 4,309

Cost of subscriber equipment sales - reduction in the value of inventory — 8,537 — 8,553

Marketing, general and administrative 10,646 9,631

Stock-based compensation

4,346 2,100 10,638 4,575

Reduction in the value of long-lived assets 305 —

1 unchanged sentence

Total operating expenses 61,192 51,453

Income (loss) from operations 2,017 ( 186,641 ) 11,828 ( 211,709 )

(Loss) income from operations ( 4,712 ) 7,191

Other (expense) income:

1 unchanged sentence

Interest income and expense, net of amounts capitalized ( 3,785 ) ( 2,032 )

Foreign currency loss ( 4,151 ) ( 9,406 ) ( 206 ) ( 13,297 )

Derivative gain (loss) and other 25 ( 884 ) 373 ( 2,223 )

Foreign currency (loss) gain ( 3,842 ) 1,907

Other ( 849 ) ( 99 )

Total other expense ( 8,476 ) ( 10,627 )

Loss before income taxes ( 13,188 ) ( 3,436 )

Income tax expense (benefit) 115 ( 153 ) 185 51

Income tax expense 8 44

Net loss $ ( 13,196 ) $ ( 3,480 )

1 unchanged sentence

Foreign currency translation adjustments 2,393 ( 1,429 )

Defined benefit pension plan liability adjustment

$ — $ 2,073 $ — $ 2,073

Comprehensive loss $ ( 10,803 ) $ ( 4,909 )

11 unchanged sentences

(In thousands, except par value and share data)

September 30, 2023 December 31, 2022

March 31, 2024 December 31, 2023

Current assets:

14 unchanged sentences

Current portion of long-term debt $ 34,600 $ 34,600

Accounts payable 3,631 3,843

Vendor financing — 59,575

Accrued expenses 24,837 22,554

Accounts payable and accrued expenses 28,268 28,985

Accrued satellite construction costs 18,796 58,187

10 unchanged sentences

Preferred Stock of $ 0.0001 par value;

99,700,000 shares authorized and none issued and outstanding at September 30, 2023 and December 31, 2022, respectively

Series A Preferred Convertible Stock of $ 0.0001 par value;

300,000 shares authorized and 149,425 issued and outstanding at September 30, 2023 and December 31, 2022, respectively

99,700,000 shares authorized and none issued and outstanding at March 31, 2024 and December 31, 2023, respectively

Series A Perpetual Preferred Stock of $ 0.0001 par value;

300,000 shares authorized and 149,425 issued and outstanding at March 31, 2024 and December 31, 2023, respectively

Voting Common Stock of $ 0.0001 par value;

2,150,000,000 shares authorized;

1,876,120,002 and 1,811,074,696 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively

1,883,934,020 and 1,881,194,682 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively

Additional paid-in capital 2,447,581 2,438,703

8 unchanged sentences

Preferred Stock Common Stock Additional

Capital Accumulated Other Comprehensive Income (Loss) Retained

Capital Accumulated Other Comprehensive Income

Deficit Total

2 unchanged sentences

Net issuance of restricted stock awards and employee stock options and recognition of stock-based compensation — — 2,739 — 11,794 — — 11,794

Contribution of services — — — — 47 — — 47

Issuance and recognition of stock-based compensation of employee stock purchase plan — — — — 102 — — 102

Series A Preferred Stock Dividends — — — — ( 2,644 ) — — ( 2,644 )

Other comprehensive loss — — — — — ( 1,429 ) — ( 1,429 )

Net loss — — — — — — ( 3,480 ) ( 3,480 )

Balances – March 31, 2023 149 $ — 1,813,112 $ 181 $ 2,345,604 $ 7,813 $ ( 2,043,744 ) $ 309,854

Net issuance of restricted stock awards and stock for employee stock options and recognition of stock-based compensation — — 363 — 1,874 — — 1,874

Contribution of services — — — — 47 — — 47

Net issuance of stock through employee stock purchase plan and recognition of stock-based compensation — — 497 — 636 — — 636

Series A Preferred Stock Dividends — — — — ( 2,644 ) — — ( 2,644 )

Fair value of Thermo guarantee associated with the 2023 Funding Agreement — — — — 6,897 — — 6,897

Other comprehensive loss — — — — — ( 1,307 ) — ( 1,307 )

Net income — — — — — — 9 9

Balances – June 30, 2023 149 $ — 1,813,972 $ 181 $ 2,352,414 $ 6,506 $ ( 2,043,735 ) $ 315,366

Net issuance of restricted stock awards and stock for employee stock options and recognition of stock-based compensation — — 2,171 1 3,870 — — 3,871

Contribution of services — — — — 47 — — 47

Series A Preferred Stock Dividends — — — — ( 2,673 ) — — ( 2,673 )

Issuance of stock in connection with License Agreement with XCOM — — 59,977 6 70,415 — — 70,421

— — — — ( 272 ) — — ( 272 )

Other comprehensive income — — — — — 2,393 — 2,393

Net loss — — — — — — ( 13,196 ) ( 13,196 )

Balances – September 30, 2023 149 — 1,876,120 $ 188 $ 2,424,073 $ 9,009 $ ( 2,049,904 ) $ 383,366

Balances – March 31, 2024 149 $ — 1,883,934 $ 188 $ 2,447,581 $ 7,463 $ ( 2,078,178 ) $ 377,054

Preferred Stock Common Stock Additional

4 unchanged sentences

Net issuance of restricted stock awards and stock for employee stock options and recognition of stock-based compensation — — 2,037 — 3,897 — — 3,897

Contribution of services — — — — 47 47

Recognition of stock-based compensation of employee stock purchase plan — — — — 117 — — 117

Common stock issued in connection with conversion of 2013 8.00 % Notes

Series A Preferred Stock Dividends — — — — ( 3,952 ) — — ( 3,952 )

— — — — 47 — — 47

2 unchanged sentences

Balances – March 31, 2023 149 $ — 1,813,112 $ 181 $ 2,345,604 $ 7,813 $ ( 2,043,744 ) $ 309,854

Net issuance of restricted stock awards and stock for employee stock options and recognition of stock-based compensation — — 546 — 879 — — 879

Contribution of services — — — — 47 — — 47

Net issuance of stock through employee stock purchase plan and recognition of stock-based compensation — — 446 — 617 — — 617

Other comprehensive income — — — — — 5,315 — 5,315

Net loss — — — — — — ( 26,757 ) ( 26,757 )

Balances – June 30, 2022 — $ — 1,800,477 $ 180 $ 2,153,195 $ 6,526 $ ( 1,830,568 ) $ 329,333

Net issuance of restricted stock awards and stock for employee stock options and recognition of stock-based compensation — — 46 — 1,815 — — 1,815

Contribution of services — — — — 47 — — 47

Recognition of stock-based compensation of employee stock purchase plan — — — — 60 — — 60

Other comprehensive income — — 8,686 8,686

Net loss — — — — — — ( 204,361 ) ( 204,361 )

Balances – September 30, 2022 — — 1,800,523 $ 180 $ 2,155,117 $ 15,212 $ ( 2,034,929 ) $ 135,580

See accompanying notes to unaudited interim condensed consolidated financial statements.

2 unchanged sentences

(In thousands)

Nine Months Ended

September 30,

2023 September 30,

Three Months Ended

2024 March 31,

Cash flows provided by operating activities:

3 unchanged sentences

Stock-based compensation expense 9,227 3,760

Noncash consideration, net, associated with wholesale capacity contract ( 2,216 ) —

Reduction in value of long-lived assets and inventory 35 175,079

Noncash interest and accretion expense 3,479 6,362

Unrealized foreign currency loss 131 13,399

Unrealized foreign currency loss (gain) 3,855 ( 1,958 )

Write off of debt discount and deferred financing costs upon extinguishment of debt — 10,194

Noncash expenses associated with SSA, net of amortization 892 —

Other, net 1,310 ( 628 )

11 unchanged sentences

Payments under the satellite procurement agreement ( 44,721 ) ( 59,575 )

Other network upgrades to support the Service Agreements ( 18,085 ) ( 18,604 )

Payments for other network upgrades to support the Service Agreements ( 3,605 ) ( 3,561 )

Payments of capitalized interest ( 3,954 ) ( 5,263 )

Network upgrades to support product development ( 4,960 ) ( 5,839 )

Payments for network upgrades to support product development ( 1,901 ) ( 2,925 )

Purchase of intangible assets ( 68 ) ( 251 )

8 unchanged sentences

Proceeds from issuance of common stock and exercise of options 653 —

Net cash provided by (used in) financing activities 105,902 ( 5,886 )

Effect of exchange rate changes on cash, cash equivalents and restricted cash ( 19 ) ( 68 )

Net increase in cash, cash equivalents and restricted cash 32,054 445

Cash, cash equivalents and restricted cash, beginning of period 32,082 14,304

Cash, cash equivalents and restricted cash, end of period $ 64,136 $ 14,749

September 30,

2023 December 31,

Reconciliation of cash and cash equivalents

Cash and cash equivalents $ 64,136 $ 32,082

Total cash and cash equivalents cash shown in the statement of cash flows $ 64,136 $ 32,082

Nine Months Ended

September 30,

2023 September 30,

Net cash provided by financing activities 27,106 37,148

Effect of exchange rate changes on cash and cash equivalents ( 137 ) 27

Net increase (decrease) in cash and cash equivalents 2,538 ( 11,595 )

Cash and cash equivalents, beginning of period 56,744 32,082

Cash and cash equivalents, end of period (1)

$ 59,282 $ 20,487

Three Months Ended

2024 March 31,

Supplemental disclosure of cash flow information:

3 unchanged sentences

Capitalized accretion of debt discount and amortization of prepaid financing costs 2,006 658

Satellite construction assets acquired through vendor financing arrangement — 69,896

Re-characterization of 2021 Funding Agreement to debt 87,950 —

Fair value of common stock issued for License Agreement 58,534 —

Fair value of common stock issued for SSA 11,887 —

Accrued satellite construction assets 18,796 48,598

Construction in progress assets acquired through XCOM SSA 1,213 —

(1) Cash and cash equivalents on the consolidated balance sheet is equal to cash and cash equivalents on the statement of cash flows

See accompanying notes to unaudited interim condensed consolidated financial statements.

11 unchanged sentences

however, management believes the disclosures made are adequate to make the information presented not misleading.

These financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Globalstar Annual Report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 1, 2023 (the “2022 Annual Report”).

These financial statements and notes should be read in conjunction with the consolidated financial statements and notes thereto included in the Globalstar Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on February 29, 2024 (the “2023 Annual Report”).

The preparation of condensed consolidated financial statements in conformity with U.S.

6 unchanged sentences

In the opinion of management, the information included herein includes all adjustments, consisting of normal recurring adjustments, that are necessary for a fair presentation of the Company’s condensed consolidated statements of operations, consolidated balance sheets, condensed consolidated statements of stockholders' equity and condensed consolidated statements of cash flows for the periods presented.

The results of operations for the three and nine months ended September 30, 2023 are not necessarily indicative of the results that may be expected for the full year or any future period.

The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the full year or any future period.

Recently Issued Accounting Pronouncements

In September 2022, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No.

Liabilities — Supplier Finance Programs (Subtopic 405-50):

Disclosure of Supplier Finance Program Obligations .

ASU 2022-04 added certain disclosure requirements for buyers in supplier finance programs.

The amendments in the update require that buyers disclose qualitative and quantitative information about their supplier finance programs.

Interim and annual requirements include disclosure of outstanding amounts under the obligations as of the end of the reporting period, and annual requirements include a rollforward of those obligations for the annual reporting period, as well as a description of payment and other key terms of the programs.

This update is effective for annual periods beginning after December 15, 2022, and interim periods within those fiscal years, except for the requirement to disclose rollforward information, which is effective for fiscal years beginning after December 15, 2023.

The Company adopted this standard when it became effective on January 1, 2023 and revised its disclosures pursuant to ASU 2022-04.

Recently Adopted Accounting Pronouncements

In January 2017, the FASB issued ASU No.

2017-04, Intangibles - Goodwill and Other (Topic 350):

Simplifying the Test for Goodwill Impairment.

ASU 2017-04 eliminates the requirement to calculate the implied fair value of goodwill, eliminating Step 2 from the goodwill impairment test.

Under ASU 2017-04, goodwill impairment will be tested by comparing the fair value of a reporting unit with its carrying amount, and recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value.

ASU 2017-04 should be applied prospectively and is effective for annual and interim periods beginning after December 15, 2022, with early adoption permitted.

Prior to August 2023, the Company did not have any recorded goodwill on its consolidated balance sheets.

In connection with the License Agreement (discussed below) entered into in August 2023, the Company recorded goodwill and is now subject to the guidance pursuant to ASU 2017-04.

The Company adopted ASU 2017-04 effective July 1, 2023.

The adoption of the new standard did not have a material impact on the Company’s consolidated financial statements.

LICENSE AGREEMENT

As more fully described in the Company’s Current Report on Form 8-K filed with the Commission on August 31, 2023, on August 29, 2023, the Company entered into an Intellectual Property License Agreement (the “License Agreement”) with XCOM Labs, Inc.

(“Licensor” or “XCOM”).

Under the License Agreement, the Company purchased an exclusive (subject to the qualifications set forth in the license agreement) right and license (the “License”) as well as Intellectual Property Assets (as defined in the License Agreement) relating to the development and commercialization of XCOM’s technologies for wireless spectrum innovations.

As consideration for the License and other agreements of Licensor in the License Agreement, the Company issued 60.6 million shares of its common stock, par value $ 0.0001 per share (the “Stock Consideration”), representing a transaction value of approximately $ 68.7 million, subject to adjustment and a holdback to provide for certain liabilities related to the Intellectual Property Assets.

The number of shares issued as Stock Consideration was calculated using the volume-weighted average market price of the Common Stock on the NYSE American for the 20 trading days immediately preceding August 29, 2023.

In connection with the License Agreement, the Company also entered into a Support Services Agreement (the “SSA”) with XCOM.

Pursuant to the SSA, XCOM is required to provide services to the Company assisting with certain operations of the business relating to the Intellectual Property Assets and to make available to the Company certain employees and facilities associated with the foregoing.

Fees payable by Globalstar pursuant to the SSA will be based on costs incurred to provide the services and will be paid in shares of Globalstar common stock or cash at its option.

The Company accounted for the License Agreement under ASC 805, Business Combinations and allocated the preliminary purchase price based on the fair value of tangible and intangible assets acquired.

If, prior to the end of the one-year measurement period for finalizing the purchase price allocation, information becomes available about facts and circumstances that existed as of the transaction date, which would indicate adjustments are required to the purchase price allocation, such adjustments will be included in the purchase price allocation retrospectively.

As discussed above, the fair value of the consideration transferred totaled $ 70.4 million and was paid in Globalstar common stock.

Approximately 18.8 million shares transferred were subject to legal trading restrictions.

These shares were valued using a Black-Scholes pricing model (refer to Note 8:

Fair Value Measurements for further discussion) and the fair value on the transaction date was $ 19.0 million.

Approximately 41.8 million shares transferred were not subject to legal trading restrictions and, pursuant to applicable accounting guidance and the Company's accounting policy election, were valued using the low price on the transaction date with a fair value of $ 51.4 million.

The fair value of the consideration transferred included $ 58.5 million associated with the purchase price and the reimbursement of the seller's transaction costs as well as $ 11.9 million associated with the initial service period under the SSA.

The Company recorded this amount as a prepaid asset on its consolidated balance sheets and will amortize the prepayment to cost of services and management, general and administrative expenses over the initial service period of nine months .

The allocation of the purchase price on August 29, 2023 is reflected in the tables below (amounts in thousands):

Identifiable assets acquired

Developed intellectual property (included in intangible assets)

Total identifiable assets acquired

Goodwill (included in intangible assets)

Net assets acquired

There were no liabilities assumed by the Company at the time of the License Agreement.

Other items in the table above include primarily equipment, inventory and the fair value of the trade name.

The table below reflects the intangible assets acquired and weighted-average useful lives (amounts in thousands):

Intangible Asset

Initial Fair Value

Weighted-Average Useful Life

Trade name (included in Other in the table above) $ 560 5

Developed intellectual property 25,980 10

The fair values of the intangible assets are provisional pending receipt of the final valuations for those assets.

The trade name was valued using an income approach, specifically a relief from royalty method.

The developed intellectual property was valued using the income approach, specifically a discounted cash flow method.

Goodwill represents the excess of the purchase price of the net identifiable tangible assets acquired.

At the transaction date, the goodwill of $ 30.6 million is attributable to the workforce of the acquired entity and significant synergies.

All of the goodwill was assigned to Globalstar's MSS business, its only reportable segment.

The total goodwill is expected to be deductible for income tax purposes.

During the three months ended September 30, 2023, the Company incurred $ 2.9 million of acquisition-related costs, which primarily consisted of transaction fees as well as legal, accounting and other professional fees.

These costs are recorded in management, general and administrative expenses on the Company's condensed consolidated statements of operations.

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") 2023-09, Income Taxes (Topic 740):

Improvements to Income Tax Disclosures , which updates qualitative and quantitative disclosures for the rate reconciliation and income taxes paid.

The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted.

The amendments should be applied prospectively;

however, retrospective application is also permitted.

The Company will adopt this standard when it becomes effective on January 1, 2025.

The Company is evaluating the impact this ASU may have on its financial statement disclosures.

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") 2023-07, Segment Reporting (Topic 280):

Improvements to Reportable Segment Disclosures , which provides updates to qualitative and quantitative reportable segment disclosure requirements, including enhanced disclosures about significant segment expenses and increased interim disclosure requirements, among others.

This ASU also explicitly requires public entities with a single reportable segment to provide all segment disclosures under ASC 280, including the new disclosures in this ASU.

The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024.

Early adoption is permitted, and the amendments should be applied retrospectively.

The Company is evaluating the impact this ASU may have on its financial statement disclosures.

Disaggregation of Revenue

The following table discloses revenue disaggregated by type of product and service (amounts in thousands):

Three Months Ended Nine Months Ended

September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022

Three Months Ended

March 31, 2024 March 31, 2023

Service revenue:

7 unchanged sentences

Subscriber equipment sales 3,015 5,690

SPOT 1,746 1,558 6,185 4,707

Commercial IoT 2,262 2,713 9,975 6,427

Other 32 54 ( 6 ) 371

Total subscriber equipment sales 4,040 4,325 16,154 11,505

Total revenue $ 56,480 $ 58,644

2 unchanged sentences

Revenue associated with the Service Agreements is included in "Wholesale capacity services" in the table above.

The Company also has an agreement with a government services company to utilize the Company's satellite network for a mission critical service for government applications.

Revenue associated with this agreement is included in "Wholesale capacity services" in the table above.

As consideration for the services provided by Globalstar under the Service Agreements, payments include a recurring service fee, payments relating to certain service-related operating expenses and capital expenditures, and potential bonus payments subject to satisfaction of certain licensing, service and other related criteria.

During the third quarter of 2023, revenue recognized in connection with the Service Agreements included approximately $ 4.4 million for a bonus earned for the

maintenance of the Company's global MSS authorizations.

During the first quarter of 2023, revenue recognized included $ 6.5 million received in connection with the amendment of the Service Agreements in February 2023 as consideration related to performance obligations completed in prior periods.

Accounts Receivable

The Company records trade accounts receivable from its customers, including MSS subscribers and its wholesale capacity customer, when it has a contractual right to receive payment either on demand or on fixed or determinable dates in the future.

In addition to receivables arising from the sale of goods or services, the Company also has certain arrangements whereby it acts as an agent to procure goods and perform services under the Service Agreements.

Receivables are included in "Accounts receivable, net of allowance for credit losses," on the Company's consolidated balance sheets except for the long-term portion of the wholesale capacity accounts receivable, which is included in "Prepaid satellite costs and customer receivable." The Company's receivable balances by type and classification are presented in the table below net of allowance for credit losses and may include amounts related to earned but unbilled receivables (amounts in thousands).

September 30, 2023 December 31, 2022

The Company records trade accounts receivable from its customers, including MSS subscribers and its wholesale capacity customers, when it has a contractual right to receive payment either on demand or on fixed or determinable dates in the future.

The Company's receivable balances by type and classification are presented in the table below net of allowance for credit losses and may include amounts related to earned but unbilled receivables (amounts in thousands).

March 31, 2024 December 31, 2023

Accounts receivable, net of allowance for credit losses

1 unchanged sentence

Wholesale capacity accounts receivable 28,221 34,269

Agency agreement accounts receivable 1,693 4,245

Total accounts receivable, net of allowance for credit losses $ 42,830 $ 48,743

Long-term wholesale capacity accounts receivable — 16,100

Total accounts receivable (short-term and long-term), net of allowance for credit losses $ 43,218 $ 42,429

During the third quarter of 2023, the Company reclassified $ 16.1 million of accounts receivable associated with the Service Agreements from long-term accounts receivable to short-term accounts receivable.

This balance is associated with amounts that are contractually owed to the Company for meeting performance obligations related to the next-generation satellite constellation prior to the Phase 2 Service Period.

The Company expects that this amount will be paid during the next twelve months.

In February 2022, the Company entered into an agreement for the purchase of new satellites that will replenish the Company's HIBLEO-4 U.S.-licensed system under the satellite procurement agreement, as amended, with Macdonald, Dettwiler and Associates Corporation ("MDA") and certain other costs incurred for the new satellites;

these payments are expected to be paid to the Company on a straight-line basis commencing with the launch of these satellites through their estimated useful life ("Phase 2 Service Period").

Based on construction in progress incurred by Globalstar, amounts expected to be billed by the Company associated with this phase of the Service Agreements wer e $ 177.7 million a s of September 30, 2023 .

In prior year filings, the Company recorded a long-term unbilled receivable and related long-term deferred revenue reflecting its Partner’s obligation to fund certain construction costs to the Company associated with the satellites that are being constructed to provide service during the Phase 2 Service Period.

During 2023, the Company revised this presentation and applied this change to its December 31, 2022 balance sheet.

This change in accounting presentation has no impact on Partner’s obligation to provide funding for the satellite construction costs nor the expected revenue the Company will recognize during the Phase 2 Service Period.

Based on construction in progress incurred by Globalstar, amounts expected to be billed by the Company associated with this phase of the Service Agreements wer e $ 208.3 million a s of March 31, 2024 .

Contract Liabilities

Contract liabilities, which are included in deferred revenue on the Company’s consolidated balance sheet, represent the Company’s obligation to transfer service or equipment to a customer from whom it has previously received consideration.

Contract liabilities reflect balances from its customers, including MSS subscribers and its wholesale capacity customer under the Service Agreements.

Contract liabilities reflect balances from its customers, including MSS subscribers and its wholesale capacity customers.

The Company's contract liabilities by type and classification are presented in the table below (amounts in thousands).

September 30, 2023 December 31, 2022

March 31, 2024 December 31, 2023

Short-term contract liabilities

Subscriber contract liabilities $ 22,869 $ 22,816

Wholesale capacity contract liabilities 33,810 52,652

Wholesale capacity contract liabilities, net of contract asset

30,888 30,861

Total short-term contract liabilities $ 53,757 $ 53,677

4 unchanged sentences

Total contract liabilities $ 55,300 $ 56,890

For subscriber contract liabilities, the amount of revenue recognized during the nine months ended September 30, 2023 and 2022 from performance obligations included in the contract liability balance at the beginning of these periods was $ 18.9 million and $ 22.8 million, respectively.

For wholesale capacity contract liabilities, the amount of revenue recognized during the nine months ended September 30, 2023 and 2022 from performance obligations included in the contract liability balance at the beginning of these periods was $ 41.6 million and less than $ 0.1 million, respectively.

For subscriber contract liabilities, the amount of revenue recognized during the three months ended March 31, 2024 and 2023 from performance obligations included in the contract liability balance at the beginning of these periods was $ 7.4 million and $ 8.4 million, respectively.

For wholesale capacity contract liabilities, the amount of revenue recognized during the three months ended March 31, 2024 and 2023 from performance obligations included in the contract liability balance at the beginning of these periods was $ 23.6 million and $ 22.0 million, respectively.

The duration of the Company’s contracts with subscribers is generally one year or less.

As of September 30, 2023, the Company expects to recognize $ 24.3 million of its remaining performance obligations to its subscribers during the next twelve months .

The Service Agreements have no expiration date;

therefore, the related contract liabilities may be recognized into revenue over various periods driven by the expected related service or recoupment periods.

As of September 30, 2023, the Company expects to recognize $ 33.8 million of its remaining performance obligations during the next twelve months .

The components of wholesale capacity contract liabilities are presented in the table below (amounts in thousands).

September 30, 2023 December 31, 2022

March 31, 2024 December 31, 2023

Wholesale capacity contract liabilities, net:

Advanced payments for services expected to be performed with the second-generation satellite constellation during Phase 1 (2)

$ 6,079 $ 99,671

Additional consideration associated with the 2021 and 2023 Funding Agreements (2)

$ 15,569 $ 16,104

Advanced payments for services expected to be performed with the ground spare satellite launched in June 2022 during Phases 1 and 2 23,233 23,673

1 unchanged sentence

Advanced payments for the Phase 1 service fee and service-related operating expenses and capital expenditures 19,871 19,907

20,496 18,872

Other advanced payments associated with future performance obligations 6,240 5,219

Contract asset (1)

1 unchanged sentence

Wholesale capacity contract liabilities, net $ 30,888 $ 32,442

(1) In November 2022, the Company issued warrants to Partner (the "Warrants").

The initial fair value of the Warrants at the time of issuance was $ 48.3 million and recorded in equity with an offset to a contract asset on the Company's consolidated balance sheets.

(1) Primarily includes warrants with an initial fair value at the time of issuance of $ 48.3 million which was recorded in equity with an offset to a contract asset on the Company's consolidated balance sheets.

The fair value of the Warrants is recorded as a reduction to revenue over the period in which the Company performs its performance obligations through the estimated completion of the contract term, consistent with the period in which the customer benefits from the services provided.

(2) During 2021, the Company received payments from Partner totaling $ 94.2 million (the "2021 Funding Agreement").

In February 2023, the Service Agreements were amended.

This amendment, which was effective in April 2023, changed certain terms in the 2021 Funding Agreement, resulting in $ 88.0 million previously recorded as deferred revenue being re-characterized as debt.

See further discussion in Note 6:

Long-Term Debt and Other Financing Arrangements.

(3) In connection with the Company recording the fair value of its financial obligations in the amended 2021 and 2023 Funding Agreements, it recorded a debt discount of $ 11.6 million and $ 4.5 million, respectively, representing the difference between the present value of the future principal payments discounted using the prevailing market rate at the date of issuance of the debt and the effective rate.

The offset was recorded to deferred revenue and is being recognized into revenue over the Phase 1 and 2 Service Periods, respectively.

The following tables disclose the components of the Company’s finance and operating leases (amounts in thousands):

September 30, 2023 December 31, 2022

Operating leases:

Right-of-use asset, net $ 34,273 $ 30,859

Short-term lease liability (recorded in accrued expenses) 2,946 2,747

Long-term lease liability 29,524 27,635

Total operating lease liabilities $ 32,470 $ 30,382

Finance leases:

Right-of-use asset, net (recorded in intangible and other current assets, net) $ 85 $ 104

Short-term lease liability (recorded in accrued expenses) 17 16

Long-term lease liability (recorded in non-current liabilities) 58 71

Total finance lease liabilities $ 75 $ 87

The components of lease cost are reflected in the table below (amounts in thousands):

Three Months Ended Nine Months Ended

September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022

Operating lease cost:

Amortization of right-of-use assets, net

$ 769 $ 369 $ 2,144 $ 1,206

Interest on lease liabilities 707 571 1,954 1,848

Finance lease cost:

Amortization of right-of-use assets 12 4 22 7

Short-term lease cost 163 205 674 413

Total lease cost $ 1,651 $ 1,149 $ 4,794 $ 3,474

Interest on finance lease liabilities was less than $ 0.1 million for the three and nine months ended September 30, 2023 and 2022;

accordingly, these amounts are not shown in the table above.

Weighted-Average Remaining Lease Term and Discount Rate

The following table discloses the weighted-average remaining lease term and discount rate for finance and operating leases.

September 30, 2023 December 31, 2022

Weighted-average lease term

Finance leases 3.9 years 4.6 years

Operating Leases 9.9 years 10.1 years

Weighted-average discount rate

Finance leases 10.2 % 10.2 %

Operating leases 8.6 % 8.5 %

Supplemental Cash Flow Information

The below table discloses supplemental cash flow information for operating leases (in thousands):

Nine Months Ended

September 30, 2023 September 30, 2022

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows for operating leases $ 4,420 $ 3,675

Operating and financing cash flows from finance leases were each less than $ 0.1 million for each of the nine months ended September 30, 2023 and 2022;

accordingly, these cash flows are not shown in the table above.

Maturity Analysis

The following table reflects undiscounted cash flows on an annual basis for the Company’s lease liabilities as of September 30, 2023 (amounts in thousands):

Operating Leases Finance Leases

2023 (remaining) $ 1,422 $ 6

2024 5,562 23

2025 5,591 23

2026 5,638 23

2027 5,516 15

Thereafter 24,119

Total lease payments $ 47,848 $ 90

Imputed interest ( 15,378 ) ( 15 )

Discounted lease liability $ 32,470 $ 75

(2) Includes debt discounts associated with the amended 2021 and 2023 Funding Agreements.

The offset was recorded to deferred revenue and is being recognized into revenue over the Phase 1 and 2 Service Periods.

PROPERTY AND EQUIPMENT

Property and equipment consists of the following (in thousands):

September 30,

2024 December 31,

15 unchanged sentences

In 2022, the Company entered into an agreement with MDA for the purchase of new satellites that will replenish the Company's HIBLEO-4 U.S.-licensed system .

This agreement had an initial contract price of $ 327 million, of which $ 182.5 million had been incurred as of September 30, 2023.

The "space component" of construction in progress in the table above includes costs incurred under the MDA contract as well as associated personnel costs and capitalized interest.

Accrued satellite construction costs on the Company's condensed consolidated balance sheets as of September 30, 2023 and December 31, 2022 included $ 65.7 million and $ 36.1 million, respectively, of work completed, but not yet invoiced, under the satellite procurement agreement.

As of September 30, 2023 and December 31, 2022, the Company also recorded $ 7.4 million and $ 11.5 million, respectively, as prepaid satellite construction costs for the first milestone payment made upon signing of the contract;

these costs are recorded in Prepaid satellite costs and customer receivable on the Company's condensed consolidated balance sheets.

In 2023, the Company entered into an agreement with SpaceX providing for the launch of the first set of satellites under the agreement with MDA.

Refer to Note 5:

Commitments and Contingencies for further discussion of these agreements.

The table below reflects the amounts recorded on the Company's consolidated balance sheet (amounts in thousands).

2024 December 31,

Satellite Procurement Agreement

Construction in progress $ 207,163 $ 198,884

Accrued construction costs 18,796 55,627

Prepaid construction costs 6,293 6,683

Launch Services Agreement

Construction in progress $ 9,920 $ 6,400

Accrued construction costs 5,728 2,560

Prepaid construction costs 5,408 5,760

Construction in progress costs are recorded in the "space component" of construction in progress in the table above.

These costs include milestones completed under the Satellite Procurement Agreement and Launch Services Agreement as well as associated personnel costs and capitalized interest.

Accrued construction costs reflect work completed, but not yet invoiced under the agreements or amounts reflected in accounts payable at the reporting date.

Prepaid construction costs reflect costs for milestone payments not yet completed and are recorded in " Prepaid satellite costs and customer receivable" on the Company's consolidated balance sheets.

The ground component of construction in progress includes costs incurred for assets to upgrade the Company's ground infrastructure, including costs associated with the procurement of new gateway antennas and gateway upgrade work in connection with the Service Agreements.

LONG-TERM DEBT AND OTHER FINANCING ARRANGEMENTS

Long-term debt and vendor financing consists of the following (in thousands):

September 30, 2023 December 31, 2022

March 31, 2024 December 31, 2023

Amount Unamortized Discount and Deferred Financing Costs Carrying

5 unchanged sentences

212,652 15,442 197,210 205,958 16,040 189,918

2019 Facility Agreement — — — 143,213 11,098 132,115

Vendor financing — — — 59,575 — 59,575

Total debt and vendor financing $ 375,388 $ 36,058 $ 339,330 $ 202,788 $ 11,098 $ 191,690

Total debt $ 434,452 $ 35,729 $ 398,723 $ 398,661 $ 38,361 $ 360,300

current portion 34,600 — 34,600 34,600 — 34,600

Long-term debt and vendor financing $ 343,188 $ 36,058 $ 307,130 $ 143,213 $ 11,098 $ 132,115

Long-term debt $ 399,852 $ 35,729 $ 364,123 $ 364,061 $ 38,361 $ 325,700

The principal amounts shown above include payment of in-kind interest, as applicable.

The carrying value is net of deferred financing costs and any discounts to the loan amounts at issuance, including accretion.

All amounts outstanding associated with the Company's vendor financing arrangement were due in March 2023 and, therefore, were reflected as a current liability on the Company's consolidated balance sheet as of December 31, 2022.

As of September 30, 2023, the current portion of long-term debt is associated with the 2021 Funding Agreement and represents the amounts to be paid under the Service Agreements during the next twelve months.

As of March 31, 2024, the current portion of long-term debt is associated with the 2021 Funding Agreement and represents the amounts to be paid under the Service Agreements during the next twelve months.

2023 Funding Agreement

In February 2023, the Company and its Partner agreed to amend its Service Agreements to provide for, among other things, payment of up to $ 252 million to the Company (the “2023 Funding Agreement”), which the Company will use to fund 50 % of the amounts due under its agreement with MDA, as well as launch, insurance and ancillary costs incurred in connection with the construction and launch of these satellites.

The 2023 Funding Agreement replaces the Company’s requirement to raise third-party financing for such costs as previously required under the Service Agreements and will be funded on a quarterly basis, as needed and subject to certain conditions in the agreement.

The remaining amount of the satellite costs is expected to be funded from Globalstar’s operating cash flows.

The first payment under the 2023 Funding Agreement was made to the Company in April 2023 in the amount of $ 87.7 million.

These proceeds were used to pay amounts owed to MDA for milestones completed as of the payment date.

The total amount paid to the Company under the 2023 Funding Agreement, including fees, is expected to be recouped from amounts payable by the Partner for services provided by the Company under the Service Agreements.

The total balance is expected to be recouped in installments for a period of 16 quarters beginning no later than the third quarter of 2025.

The balance may also be repaid over time through excess cash flow sweeps or voluntary prepayments, as provided under the terms of the 2023 Funding Agreement.

For as long as any amount funded under the 2023 Funding Agreement is outstanding, the Company will be subject to certain covenants, including (i) maintenance of a minimum cash balance of $ 30 million, (ii) interest coverage and leverage ratios, and (iii) other customary negative covenants, including limitations on certain asset transfers, expenditures and investments.

Thermo has agreed to provide support of certain of the Company’s obligations under the 2023 Funding Agreement.

Currently, this support agreement is directly between Thermo and Partner, and the parties have agreed to replace it with agreement between Thermo, the Company and the Partner.

Entry into this guarantee agreement received shareholder approval in June 2023, and it is expected to be effective during the fourth quarter of 2023.

In 2023, the Service Agreements were amended to provide for, among other things, payment of up to $ 252 million to the Company (the “2023 Funding Agreement”), which the Company intends to use to fund 50 % of the amounts due under its agreement with MDA, as well as launch, insurance and ancillary costs incurred in connection with the construction and launch of these satellites.

During 2024, the Company received proceeds of $ 37.7 million.

The total amount paid to the Company under the 2023 Funding Agreement, including fees, is expected to be recouped from amounts payable under the Service Agreements beginning no later than the third quarter of 2025.

For as long as any amount funded under the 2023 Funding Agreement is outstanding, the Company will be subject to certain covenants.

The Company’s obligations under the 2023 Funding Agreement are secured by a first-priority lien over substantially all of the assets of the Company and its domestic subsidiaries.

Thermo guaranteed certain of the Company’s obligations under the 2023 Funding Agreement and Service Agreements.

See further discussion regarding Thermo's guarantee in Note 6:

Related Party Transactions.

The Company recorded the fair value of the 2023 Funding Agreement using a discounted cash flow model.

The Company recorded debt discounts for the difference between the fair value of the debt and the proceeds received.

This difference is

attributed to the fair value of the Thermo guarantee (recorded as additional paid in capital) and the fair value of the economic benefit received due to the existing customer relationship (recorded as deferred revenue);

both of these debt discounts are netted against the face value of the 2023 Funding Agreement.

The Company is accreting the debt discounts to interest expense through the maturity date using an effective interest rate method.

Additionally, the prepayment features included in the 2023 Funding Agreement required bifurcation from the debt and were valued separately.

The Company recorded the embedded derivative liability as a non-current liability on its condensed consolidated balance sheet with a corresponding debt discount, which is netted against the face value of the 2023 Funding Agreement.

The Company is accreting the debt discount associated with the embedded derivative liability to interest expense through the maturity date using an effective interest rate method.

Refer to Note 7:

Derivatives and Note 8:

Fair Value Measurements for further discussion on the compound embedded derivative bifurcated from the 2023 Funding Agreement.

As the Company makes additional draws under the 2023 Funding Agreement, the amount of each draw will be recorded at fair value and the Company will assess the fair value of embedded features within the debt.

The table below outlines the components of the first draw under the 2023 Funding Agreement at funding (amounts in thousands):

Principal $ 87,730

Debt Discount - Thermo Guarantee ( 6,897 )

Debt Discount - Customer Relationship ( 4,509 )

Debt Discount - Embedded Derivative ( 341 )

Fair Value at Issuance $ 75,983

As the Company makes draws under the 2023 Funding Agreement, the amount of each draw is recorded at fair value using a discounted cash flow model.

The Company records a debt discount for the difference between the fair value of the debt and the proceeds received and accretes this debt discount to interest expense through the maturity date using an effective interest rate method.

The total proceeds of the February 2024 draw were $ 37.7 million with a fair value of $ 37.2 million.

This difference was attributed to the economic benefit received due to the existing customer relationship.

2021 Funding Agreement

During 2021, the Company received payments under the 2021 Funding Agreement totaling $ 94.2 million.

In connection with the February 2023 amendment of the Service Agreements (discussed above), certain terms of the 2021 Funding Agreement were amended to align with the terms of the 2023 Funding Agreement, including granting Partner a first-priority lien in substantially all of the assets of the Company and its domestic subsidiaries to secure the Company's repayment of amounts funded.

This amendment resulted in the Company re-characterizing the previously recorded deferred revenue to debt.

On the amendment date, the Company recorded the funding under the 2021 Funding Agreement at fair value, net of a debt discount.

The Company is accreting the debt discount to interest expense through the maturity date using an effective interest rate method.

The table below outlines the components of the 2021 Funding Agreement (amounts in thousands):

Principal $ 94,200

Amount Repaid Prior to Amendment

Debt Discount - Customer Relationship ( 11,626 )

Fair Value at Issuance $ 76,324

During 2021, the Company received payments under the amended 2021 Funding Agreement, totaling $ 94.2 million.

The Company's obligations under the 2021 Funding Agreement are secured by a first-priority lien in substantially all of the assets of the Company and its domestic subsidiaries.

This funding is being recouped as services are performed by the Company over the Phase 1 Service Period.

2023 13 % Notes

In March 2023, the Company completed the sale of $ 200.0 million in aggregate principal amount of non-convertible 13 % Senior Notes due 2029 (the “2023 13 % Notes”).

The 2023 13 % Notes were sold pursuant to a Purchase Agreement (the “Purchase Agreement”) dated March 28, 2023 among the Company, as issuer, the subsidiary guarantors party thereto (each, a “Subsidiary Guarantor” and collectively, the “Subsidiary Guarantors”), an affiliate of Värde Partners and the other purchasers party thereto (collectively, the “Purchasers”).

The 2023 13 % Notes were issued pursuant to an indenture, dated as of March 31, 2023 (the “Indenture”), among the Company, the Subsidiary Guarantors, as guarantors, and Wilmington Trust, National Association, as trustee.

The 2023 13 % Notes are senior, unsecured obligations of the Company and have a stated maturity of September 15, 2029.

The 2023 13 % Notes were sold at an issue price of 95 % of the principal amount of the 2023 13 % Notes.

The Company used a portion of the net proceeds to pay financing costs of $ 7.8 million, which were recorded on the Company's condensed consolidated balance sheet as a reduction in the carrying amount of the debt.

The 2023 13 % Notes bear interest initially at a rate of 13.00 % per annum payable semi-annually in arrears.

The Company is required to pay interest (i) at a rate per annum of 4.00 % which must be paid in cash and (ii) at a rate per annum of 9.00 % which may be paid either (a) in-kind (“PIK”) by increasing the principal amount of the 2023 13 % Notes outstanding or (b) in cash, in such proportion as the Company may choose, with a step up in the PIK component of the interest if any 2023 13 % Notes remain outstanding after March 15, 2028.

In 2023, the Company completed the sale of $ 200.0 million in aggregate principal amount of non-convertible 13 % Senior Notes due 2029 (the “2023 13 % Notes”).

The 2023 13 % Notes are senior, unsecured obligations of the Company, have a stated maturity of September 15, 2029 and bear interest initially at a rate of 13.00 % per annum payable semi-annually in arrears.

Pursuant to the Service Agreements, the Company has agreed to pay cash interest on the 2023 13 % Notes at a rate of 6.5 % per annum and PIK interest at a rate of 6.5 % per annum.

The 2023 13 % Notes may be redeemed at the option of the Company at any time, subject to the conditions of the Indenture.

Among other things, prior to March 15, 2025 (the “First Call Date”), the Company will be permitted to redeem the 2023 13 % Notes in whole or in part at the redemption price equal to 100 % of the principal amount of the 2023 13 % Notes redeemed plus a premium based on the net present value of the remaining interest payments through the First Call Date.

Beginning on the First Call Date, the 2023 13 % Notes may be redeemed at a redemption price equal to 103 % of the principal amount, declining to 100 % of the principal amount after March 15, 2027, in each case, together with accrued and unpaid interest.

Additionally, in the event of a Change of Control (as such term is defined in the Indenture) or certain other events, holders of the 2023 13 % Notes have the right to require the Company to repurchase all or a portion of their 2023 13 % Notes at a price (as calculated by the Company) in cash equal to 101 % of the aggregate principal amount thereof plus accrued and unpaid interest and certain tax payments.

The Indenture includes customary terms and covenants, including restrictions on the Company’s and the Subsidiary Guarantors’ ability to incur indebtedness, make guarantees, sell equity interests, and customary events of default after which the holders may accelerate the maturity of the 2023 13 % Notes and become due and payable immediately.

2019 Facility Agreement

In November 2019, the Company entered into a $ 199.0 million facility agreement with Thermo, an affiliate of EchoStar Corporation and certain other unaffiliated lenders (the "2019 Facility Agreement").

The 2019 Facility Agreement was scheduled to mature in November 2025.

The loans under the 2019 Facility Agreement bore interest at a rate of 14.0 % per annum to be paid in kind (or in cash at the option of the Company).

The Service Agreements required the Company to refinance all loans outstanding under the 2019 Facility Agreement.

A portion was refinanced in November 2022 and the remaining portion was refinanced in March 2023.

Using a portion of the proceeds from the sale of the 2023 13 % Notes, the Company repaid all of its outstanding obligations under the 2019 Facility Agreement of approximately $ 148 million.

The Company recorded a loss on extinguishment of debt of $ 10.4 million in the first quarter of 2023 representing the difference between the net carrying amount prior to extinguishment (including unamortized deferred financing costs, debt discounts and derivatives) and the reacquisition price of the debt.

Refer to Note 7:

Derivatives and Note 8:

Fair Value Measurements for further discussion on the compound embedded derivative bifurcated from the 2019 Facility Agreement.

Vendor Financing

In February 2022, the Company entered into a satellite procurement agreement with MDA (see Note 9:

Commitments and Contingencies for further discussion).

This agreement (as amended in October 2022 and January 2023) provided for deferrals of milestone payments through March 15, 2023.

Interest accrued on the amount outstanding at an annual rate of 7 %, which increased to 10.5 % on balances between December 2022 and March 2023.

The Company has made payments totaling $ 76.1 million to MDA under this vendor financing arrangement, of which $ 62.1 million (including $ 2.5 million of interest) was paid during the first quarter of 2023 to fully repay the outstanding vendor financing balance.

Reflected in the table below is a rollforward of the Company's obligations under its vendor financing arrangement with MDA (amounts in thousands):

Confirmed obligations outstanding, January 1, 2023 and 2022, respectively $ 59,575 $ —

Invoices confirmed during the periods — 73,575

Confirmed invoices paid during the periods ( 59,575 ) ( 14,000 )

Confirmed obligations outstanding, September 30, 2023 and December 31, 2022, respectively

In March 2024, the Company made an interest payment totaling $ 13.4 million, of which $ 6.7 million was paid in cash and $ 6.7 million was paid-in-kind, increasing the principal balance outstanding under the 2023 13 % Notes.

Series A Preferred Stock

In November 2022, the Company issued 149,425 shares of its 7.0 % Perpetual Preferred Stock, Series A, liquidation preference $ 1,000 per share (the “Series A Preferred Stock”) in exchange for $ 149.4 million outstanding principal amount of its 2019 Facility Agreement held by affiliates of Thermo and certain other lenders.

The Company recorded the Series A Preferred Stock at fair value of the shares totaling $ 105.3 million on its consolidated balance sheet.

Holders of Series A Preferred Stock are entitled to receive, when, as and if declared by the Company's Board of Directors or a committee thereof, cumulative cash dividends based on the liquidation preference of the Series A Preferred Stock, at a fixed rate equal to 7.00 % per annum, payable quarterly in arrears on January 1, April 1, July 1 and October 1 of each year.

The table below reflects the dividends approved by the Company's Board of Directors (amounts in thousands):

Payment Period Payment Date Payment Amount

November 15, 2022 - December 31, 2022 January 2023 $ 1,337

January 1, 2023 - March 31, 2023 April 2023 2,615

April 1, 2023 - June 30, 2023 June 2023 2,644

July 1, 2023 - September 30, 2023

September 2023 2,673

In 2022, the Company issued 149,425 shares of its 7.0 % Perpetual Preferred Stock, Series A, liquidation preference $ 1,000 per share (the “Series A Preferred Stock”) with a fair value of $ 105.3 million.

The shares of Series A Preferred Stock do not possess voting rights, other than certain matters specifically affecting the rights and obligations of the Series A Preferred.

Series A Preferred Stock may be redeemed by the Company, in whole or in part, at any time.

The holders of the Series A Preferred Stock do not have any rights to convert or require the Company to redeem such stock.

The Company has identified various embedded derivatives resulting from certain features in the Company’s borrowing arrangements, requiring recognition on its consolidated balance sheets.

None of these derivative instruments are designated as a hedge.

Derivative liabilities are recorded in "Other non-current liabilities" on the Company's consolidated balance sheet.

The fair value of each embedded derivative is marked-to-market at the end of each reporting period, or more frequently as deemed necessary, with any changes in value reported in the Company's condensed consolidated statements of operations and its condensed consolidated statements of cash flows as a non-cash operating activity.

The instruments and related features embedded in the debt instruments that are required to be accounted for as derivatives are described below.

Fair Value Measurements for further discussion.

2023 Funding Agreement

The 2023 Funding Agreement contains certain prepayment features that are required to be bifurcated and recorded as an embedded derivative liability on the Company's condensed consolidated balance sheet with a corresponding debt discount that is netted against the principal amount of the draws under the 2023 Funding Agreement.

The Company determined the fair value of the embedded derivative liability using a discounted cash flow model.

During the three and nine months ended September 30, 2023, the Company recorded a derivative loss of $ 0.1 million and a derivative gain of $ 0.2 million, respectively, which is reflected in derivative gain (loss) and other in the Company’s condensed consolidated statement of operations.

As of September 30, 2023, the fair value of the embedded derivative within the 2023 Funding Agreement was $ 0.1 million.

Compound Embedded Derivative within 2013 8.00 % Notes

The 2013 8.00 % Notes contained a conversion option and contingent put feature that were required to be bifurcated and recorded as a compound embedded derivative.

The Company determined the fair value of the compound embedded derivative liability using a Monte Carlo simulation model.

During the nine months ended September 30, 2022, the Company recorded a derivative gain totaling $ 0.2 million, which is reflected in derivative gain (loss) and other in the Company’s condensed consolidated statement of operations.

During the first quarter of 2022, the remaining principal amount of the 2013 8.00 % Notes was converted into shares of Globalstar common stock;

accordingly, the associated derivative was extinguished and is no longer outstanding.

Compound embedded derivative within the 2019 Facility Agreement

The 2019 Facility Agreement contained certain contingently exercisable put features that were required to be bifurcated and recorded as a compound embedded derivative.

The Company determined the fair value of this derivative using a probability weighted discounted cash flow model.

During the three and nine months ended September 30, 2022, the Company recorded a derivative gain totaling $ 0.7 million and a derivative loss totaling $ 1.3 million, respectively, which is reflected in derivative gain (loss) and other in the Company’s condensed consolidated statement of operations.

As of December 31, 2022, the fair value of the compound embedded derivative within the 2019 Facility Agreement was $ 0.1 million.

In November 2022, the Company exchanged a portion of the 2019 Facility Agreement into Series A Preferred Stock.

In March 2023, the Company refinanced the remaining principal outstanding under the 2019 Facility Agreement with proceeds from the issuance of its 2023 13 % Notes.

As a result of this activity, the Company wrote off the embedded derivative associated with the 2019 Facility Agreement, which is included in "Loss on extinguishment of debt" on the condensed consolidated statement of operations;

therefore, no balance remained as of March 31, 2023.

Long-Term Debt and Other Financing Arrangements for further discussion.

FAIR VALUE MEASUREMENTS

The Company follows the authoritative guidance for fair value measurements relating to financial and non-financial assets and liabilities, including presentation of required disclosures herein.

This guidance establishes a fair value framework requiring the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities.

Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment.

The three levels are defined as follows:

Unadjusted quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.

Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability.

Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

Recurring Fair Value Measurements

The Company marks-to-market its derivatives at each reporting date, or more frequently as deemed necessary, with the changes in fair value recognized in the Company’s consolidated statements of operations.

Derivatives for further discussion.

Embedded Derivative within the 2023 Funding Agreement

The embedded derivative associated within the 2023 Funding Agreement is valued using a discounted cash flow model.

The most significant observable input used in the fair value measurement is the discount yield, which was 8.73 % at September 30, 2023 and 8.52 % at issuance.

As the discount yield used in the valuation increases, the fair value of the embedded derivative increases.

The significant unobservable input used in the fair value measurement includes estimated timing and amounts of cash flows associated with the prepayment features within the debt agreement.

As projected cash flows increase, the fair value of the embedded derivative increases.

As of September 30, 2023, the embedded derivative within the 2023 Funding Agreement was categorized as a Level 3 fair value and was $ 0.1 million.

Compound Embedded Derivative within the 2019 Facility Agreement

The compound embedded derivative within the 2019 Facility Agreement was valued using a probability weighted discounted cash flow model.

The most significant observable input used in the fair value measurement was the discount yield.

The unobservable inputs used in the fair value measurement included the probability of change of control and the estimated timing and amounts of cash flows associated with certain mandatory prepayments within the debt agreement.

As of December 31, 2022, the compound embedded derivative within the 2019 Facility Agreement was categorized as a Level 3 fair value and was $ 0.1 million.

In March 2023, the Company refinanced the remaining principal balance outstanding under the 2019 Facility Agreement and wrote off the associated embedded derivative balance;

therefore, no balance remained as of March 31, 2023.

Rollforward of Recurring Level 3 Assets and Liabilities

The following table presents a rollforward for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) (in thousands):

Nine Months Ended September 30, 2023 Twelve Months Ended December 31, 2022

Balance at beginning of period, January 1, 2023 and 2022, respectively $ ( 122 ) $ ( 880 )

Issuance of embedded derivative within the 2023 Funding Agreement ( 341 ) —

Derivative adjustment related to conversions — 1,563

Derivative adjustment related to extinguishment of debt 122 —

Unrealized gain (loss), included in derivative gain (loss) and other 243 ( 805 )

Balance at end of period, September 30, 2023 and December 31, 2022, respectively

$ ( 98 ) $ ( 122 )

Nonrecurring Fair Value Measurements

2023 Funding Agreement

As previously discussed, the Company entered into the 2023 Funding Agreement in February 2023.

Significant quantitative Level 3 inputs were utilized in the valuation model as of the first draw date on April 18, 2023.

The Company's first draw under the 2023 Funding Agreement occurred in April 2023 with a total fair value of $ 76.0 million calculated as the projected future cash flows discounted using the prevailing market rate of interest for a similar transaction.

The discount yield used for this calculation was 8.52 %.

Amounts payable under the 2023 Funding Agreement, are expected to be guaranteed by Thermo under a guarantee agreement among Thermo, the Company and the Partner.

The Company recorded a total fair value of $ 6.9 million for this embedded feature, which was calculated as the difference in projected cash flows with and without the guarantee agreement discounted using calculated rates of 6.22 % and 8.52 %, respectively.

2021 Funding Agreement

In connection with the re-characterization of the 2021 Funding Agreement from deferred revenue to debt, the Company recorded the fair value of the debt calculated as the projected cash flows discounted using the prevailing market rate of interest for a similar transaction.

The discount yield used for this calculation was 8.52 %.

The total fair value of the 2021 Funding Agreement was $ 76.3 million and was recorded on the Company's condensed consolidated balances sheet during the second quarter of 2023 when the amendment was effective.

License Agreement

In connection with the License Agreement discussed in Note 2:

License Agreement, the consideration paid was in the form of Globalstar common stock.

Approximately 41.8 million shares were not subject to legal trading restrictions and were valued using the low stock price on the transaction date, which was $ 1.23 per share.

The total fair value of these shares was $ 51.4 million on the transaction date.

The remaining shares, totaling 18.8 million, were subject to legal trading restrictions and were valued using a Black-Scholes pricing model on the transaction date.

The total fair value of these shares was $ 19.0 million and computed using the following assumptions on the transaction date:

Underlying Stock Price and

Exercise Price

Risk-Free Interest Rate

Fair Value of Consideration

$ 1.13 0.5 74.5 % 5.52 %

Performance Share Units

During the third quarter of 2023, the Company granted 44.5 million restricted stock units ("RSUs") to certain employees which are earned over a four-year performance period.

The RSUs vest upon the Company's common stock trading at various price levels throughout the performance period.

The RSUs were valued using a Monte Carlo simulation model.

As of the grant date, September 25, 2023, the fair value of the RSUs was $ 39.5 million.

This total fair value will be recognized over the derived service period for each tranche within the grant.

The Monte Carlo simulation was computed using the following assumptions:

Risk-Free Interest Rate

Stock Price Volatility

Market Price of Common Stock

Fair Value of RSUs

4.73 % 80.00 % $ 1.29

During 2024, the Company paid dividends approved by the Company's Board of Directors totaling $ 2.6 million.

Fair Value of Debt and Other Financing Arrangements

1 unchanged sentence

Unlike typical long-term debt, certain terms for these instruments are not readily available and generally involve a variety of factors, including due diligence by the debt holders.

The Company's vendor financing arrangement was recorded at net carrying value, which approximated fair value.

Long-Term Debt and Other Financing Arrangements for further discussion of the Company's debt instruments.

COMMITMENTS AND CONTINGENCIES

4 unchanged sentences

Satellite Procurement Agreement and Launch Services Agreement

As previously disclosed, the Company’s satellite procurement agreement provides for the Company to acquire at least 17 and up to 26 satellites at an initial contract price of $ 327 million, with initial delivery expected to occur in 2025.

As more fully described in our Current Report on Form 8-K filed with the Commission on August 31, 2023, the Company’s Launch Services Agreement provides for the launch of the first set of these satellites.

The Company has a satellite procurement agreement with MDA pursuant to which the Company will acquire at least 17 satellites (and up to 26 satellites) with an amended contract price of $ 329.5 million, with initial delivery expected to occur in 2025.

In addition, MDA will procure a satellite operations control center for $ 4.9 million as well as other equipment for $ 3.7 million.

As more fully described in the Company's Current Report on Form 8-K filed with the Commission on August 31, 2023, Globalstar entered into a Launch Services Agreement by and between the Company and SpaceX and certain related ancillary agreements (the “Launch Services Agreements”), providing for the launch of the first set of the satellites the Company is acquiring pursuant to the satellite procurement agreement with MDA.

The Launch Services Agreements provide a launch window from April to September 2025.

The Service Agreements provide for the Company to receive service payments equal to 95 % of the approved capital expenditures under each contract.

RELATED PARTY TRANSACTIONS

Transactions with Thermo

Thermo is the principal owner and largest stockholder of Globalstar.

1 unchanged sentence

Two other members of the Company's Board of Directors are also directors, officers or minority equity owners of various Thermo entities.

Payables to Thermo related to normal purchase transactions were $ 0.2 million and $ 0.3 million as of September 30, 2023 and December 31, 2022, respectively.

Transactions with Thermo

Payables to Thermo related to normal purchase transactions were $ 0.3 million and $ 0.5 million as of March 31, 2024 and December 31, 2023, respectively.

Certain general and administrative expenses are incurred by Thermo on behalf of the Company.

These expenses include:

i) non-cash expenses, such as stock compensation costs as well as costs recorded as a contribution to capital as they relate to services provided by certain executive officers of Thermo, and ii) expenses incurred by Thermo on behalf of the Company that are charged to the Company;

i) non-cash expenses, such as stock compensation costs as well as costs recorded as a contribution to capital and ii) expenses incurred by Thermo on behalf of the Company that are charged to the Company;

these charges are based on actual amounts (with no mark-up) incurred by Thermo or upon allocated employee time.

Lease Agreement

The Company has a lease agreement with Thermo Covington, LLC for the Company's headquarters office.

2 unchanged sentences

The lease term is ten years and will expire in January 2029.

During each of the nine months ended September 30, 2023 and 2022, the Company incurred lease expense of $ 1.2 million under this lease agreement.

To fulfill its obligations under the Service Agreements, in November 2022, the Company entered into an Exchange Agreement with Thermo and certain other exchanging lenders providing for the exchange of all the outstanding principal amount of, and accrued and unpaid interest on, the exchanging lenders’ loans under the 2019 Facility Agreement for shares of the Company's Series A Preferred Stock.

The terms of the Exchange Agreement were reviewed and approved by the Company's Board of Directors and Audit Committee.

Thermo's ownership portion in the Series A Preferred Stock is $ 136.7 million.

During each of the three months ended March 31, 2024 and 2023, the Company incurred lease expense of $ 0.4 million under this lease agreement.

Perpetual Preferred Stock

Thermo's ownership portion in the Company's Series A Preferred Stock is $ 136.7 million.

Holders of Series A Preferred Stock are entitled to receive, when, as and if declared by our Board of Directors, cumulative cash dividends based on the liquidation preference of the Series A Preferred Stock, at a fixed rate equal to 7.00 % per annum, payable quarterly in arrears on January 1, April 1, July 1 and October 1 of each year.

During 2023, the Company paid Thermo dividends of $ 1.2 million for the period November 15, 2022 through December 31, 2022 and $ 2.4 million for each of the first, second and third quarters of 2023.

Also in connection with the Service Agreements, Partner and Thermo entered into a lock-up and right of first offer agreement that generally (i) requires Thermo to offer any shares of Globalstar common stock to Partner before transferring them to any other Person other than affiliates of Thermo and (ii) prohibits Thermo from transferring shares of Globalstar common stock if such transfer would cause Thermo to hold less than 51.00 % of the outstanding common stock of the Company for a period of five years from the launch of Services in November 2022.

Amounts payable by the Company in connection with the 2023 Funding Agreement are expected to be guaranteed by Thermo under a guarantee agreement among Thermo, the Company and the Partner.

Thermo has agreed to provide support of certain of the Company’s obligations under the 2023 Funding Agreement.

Currently this support agreement is directly between Thermo and Partner, and the parties have agreed to replace it with an agreement between Thermo, the Company and the Partner.

Entry into this guarantee agreement received shareholder approval in June 2023, and it is expected to be effective during the fourth quarter of 2023.

As consideration for Thermo's guarantee, the Company will issue to Thermo warrants to purchase 10.0 million shares of the Company’s common stock at an exercise price equal to $ 2.00 per share (as calculated pursuant to the agreement).

5.0 million of these warrants vest immediately upon effectiveness of Thermo's guarantee, which is expected to occur during the fourth quarter of 2023, and the remaining 5.0 million warrants vest if and when Thermo advances aggregate funds of $ 25.0 million or more to the Company or a permitted third party pursuant to the terms of Thermo's guarantee.

During the first quarter of 2024, the Company made dividend payments to Thermo, which were approved by the Company's Board of Directors, totaling $ 2.4 million.

Service Agreements

In connection with the Service Agreements, Partner and Thermo entered into a lock-up and right of first offer agreement that generally (i) requires Thermo to offer any shares of Globalstar common stock to Partner before transferring them to any other Person other than affiliates of Thermo and (ii) prohibits Thermo from transferring shares of Globalstar common stock if such transfer would cause Thermo to hold less than 51.00 % of the outstanding common stock of the Company for a period of five years from the launch of Services in November 2022.

Guaranty with 2023 Funding Agreement

Amounts payable by the Company in connection with the 2023 Funding Agreement and certain other obligations under the Service Agreements are guaranteed by Thermo.

As consideration for Thermo's guarantee, the Company issued to Thermo warrants to purchase 10.0 million shares of the Company’s common stock at an exercise price equal to $ 2.00 per share (as calculated pursuant to the agreement).

5.0 million of these warrants vested immediately upon effectiveness of Thermo's guarantee, which occurred in December 2023, and the remaining 5.0 million warrants vest if and when Thermo advances aggregate funds of $ 25.0 million or more to the Company or a permitted third party pursuant to the terms of Thermo's guarantee.

These warrants expire five years after the date of issuance.

Long-Term Debt and Other Financing Arrangements for further discussion of the Company's debt and financing transactions with Thermo.

In connection with the XCOM transaction, a portion of the Stock Consideration was resold by XCOM to certain long-term investors of Globalstar and XCOM (the “Resale Purchasers”), including Thermo, in private resale transactions exempt from registration under the Securities Act.

Together with shares it received for release of debt owed to it by Licensor, Thermo acquired 4.2 million total shares.

License Agreement for further discussion.

To the extent Thermo is required to advance amounts under the guarantee, the Company is required to issue shares of Common Stock of the Company in respect of such advance in an amount equal to the amount of such payment divided by the average of the volume weighted average price of the Company’s common stock on the five trading days immediately preceding such payment.

The Company has a Strategic Review Committee that is required to remain in existence for as long as Thermo and its affiliates beneficially own forty-five percent ( 45 %) or more of Globalstar’s outstanding common stock.

To the extent permitted by applicable law, the Strategic Review Committee has exclusive responsibility for the oversight, review and approval of, among other things and subject to certain exceptions, any acquisition by Thermo and its affiliates of additional newly-issued securities of the Company and any transaction between the Company and Thermo and its affiliates with a value in excess of $ 250,000 .

Agreements with XCOM Labs, Inc.

Jacobs is the Chief Executive Officer of Globalstar and also serves as the Executive Chairman of Virewirx (formerly XCOM Labs) and is the controlling stockholder of Virewirx.

In connection with the August 2023 License Agreement, Globalstar issued 60.6 million shares of its common stock, representing a transaction value of approximately $ 68.7 million, to XCOM.

The Company and XCOM also executed a Support Services Agreement ("SSA") pursuant to which XCOM is required to provide certain services to the Company.

Fees payable by Globalstar pursuant to the SSA are based on costs incurred and the first payment of $ 11.9 million was paid in August 2023 and is associated with an initial service period of nine months under the SSA.

Of the consideration paid for the License Agreement, 16.7 million shares were issued to Dr.

Jacobs does not have any family relationships with any director or executive officer of the Company and has not been directly or indirectly involved in any related party transactions with the Company, except for transactions related to the License Agreement and the SSA.

NET LOSS PER SHARE

The following table sets forth the computation of basic and diluted loss per common share during each of the three and nine months ended September 30, 2023 and 2022 (amounts in thousands, except per share data):

Three Months Ended Nine Months Ended

September 30, 2023 September 30, 2022 September 30, 2023 September 30, 2022

The following table sets forth the computation of basic and diluted loss per common share during each of the three months ended March 31, 2024 and 2023 (amounts in thousands, except per share data):

Three Months Ended

March 31, 2024 March 31, 2023

$ ( 13,196 ) $ ( 3,480 )

3 unchanged sentences

Net loss per common share - basic and diluted $ ( 0.01 ) $ 0.00

For the three months ended September 30, 2023 and 2022, 17.8 million and 9.4 million shares, respectively, of potential common stock were excluded from diluted shares outstanding because the effects of potentially dilutive securities would be anti-dilutive.

For the nine months ended September 30, 2023 and 2022, 17.5 million and 8.8 million shares, respectively, of potential common stock were excluded from diluted shares outstanding because the effects of potentially dilutive securities would be anti-dilutive.

Included in these shares as of September 30, 2023 is a portion of the 49.1 million Warrants issued under the Service Agreements in 2022, which was determined after considering the exercise price of each tranche relative to the average market price during the period.

Excluded from the amounts above are warrants expected to be issued to Thermo for its guarantee of the 2023 Funding Agreement totaling 10.0 million;

the guarantee is expected to become effective during the fourth quarter of 2023.

In the third quarter of 2023, the Company granted 44.5 million restricted stock units containing market conditions determined by the Company's stock price.

As calculated in accordance with applicable accounting guidance, these shares are excluded from the basic and dilutive share count above for the three and nine months ended September 30, 2023.

For the three months ended March 31, 2024 and 2023, 21.0 million and 19.7 million shares, respectively, of potential common stock were excluded from diluted shares outstanding because the effects of potentially dilutive securities would be anti-dilutive.

Included in these shares as of March 31, 2024 is a portion of the 49.1 million Warrants issued under the Service Agreements in 2022 based on the treasury stock method.

During 2023, 5.0 million of the warrants that were issued to Thermo for its guarantee of the 2023 Funding Agreement vested;

none of these warrants are included in the potentially dilutive securities for the period due to the exercise price of the warrants relative to the average market price of Globalstar common stock during the period.

Also excluded from the amounts above are 5.0 million unvested warrants associated with Thermo's guarantee of the 2023 Funding Agreement;

these warrants vest only if Thermo advances aggregate funds of $ 25.0 million or more to the Company or a permitted third party pursuant to the terms of Thermo's guarantee.

As discussed in Note 4:

Long-Term Debt and Other Financing Arrangements, the Company's Board of Directors approved the payment of dividends totaling $ 2.7 million and $ 7.9 million for the three and nine months ended September 30, 2023, respectively, on its Series A Preferred Stock.

Long-Term Debt and Other Financing Arrangements, the Company's Board of Directors approved the payment of dividends totaling $ 2.6 million for each of the three months ended March 31, 2024 and 2023, respectively, on its Series A Preferred Stock.

This amount adjusts the numerator used to calculate loss per share.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1. Financial Statements